Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transplantation Phase II
NCT00676806Phase 2Terminated
- Sponsor
- Tufts Medical Center
- Start
- Jul 2005
- Primary completion
- Jul 2013
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in leukemia, lymphoma, multiple myeloma (MM), aplastic anemia, Inborn errors of metabolism (IEM), sponsored by Tufts Medical Center. Started Jul 2005; status: terminated.
02
Drugs
umbilical cord blood
03
Conditions
leukemialymphomamultiple myeloma (MM)aplastic anemiaInborn errors of metabolism (IEM)
Beyond the preview
Go deeper on NCT00676806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676806.